DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 52-Week Low - Here's What Happened

Key Points

• DENTSPLY SIRONA's stock reached a new 52-week low at $12.14 during trading, closing at $12.29 with a volume of 410,887 shares exchanged.
• Multiple analysts have recently downgraded their price targets for DENTSPLY SIRONA, with the average target now at $18.64, while about 95% of the stock is held by institutional investors.
• The company reported earnings of $0.52 per share, surpassing consensus estimates, but experienced a 4.9% decline in revenue compared to the same quarter last year.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s stock price reached a new 52-week low during trading on Friday . The company traded as low as $12.14 and last traded at $12.29, with a volume of 410887 shares traded. The stock had previously closed at $12.21.

Wall Street Analysts Forecast Growth

XRAY has been the topic of a number of recent research reports. Wells Fargo & Company cut their price objective on DENTSPLY SIRONA from $16.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Friday, August 8th. Stifel Nicolaus dropped their price target on shares of DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday, August 8th. Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, August 8th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a report on Friday. Two analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $18.64.

DENTSPLY SIRONA Stock Up 0.7%

The stock has a market capitalization of $2.45 billion, a P/E ratio of -2.59, a PEG ratio of 0.80 and a beta of 0.96. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The stock's fifty day moving average is $14.20 and its two-hundred day moving average is $14.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm had revenue of $936.00 million during the quarter, compared to analysts' expectations of $929.67 million. During the same period last year, the firm posted $0.49 earnings per share. The firm's revenue for the quarter was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 5.2%. The ex-dividend date is Friday, September 26th. DENTSPLY SIRONA's payout ratio is -13.50%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Deutsche Bank AG boosted its stake in DENTSPLY SIRONA by 29.7% in the 4th quarter. Deutsche Bank AG now owns 15,720 shares of the medical instruments supplier's stock worth $298,000 after purchasing an additional 3,603 shares during the period. Tidal Investments LLC boosted its position in DENTSPLY SIRONA by 15.5% during the fourth quarter. Tidal Investments LLC now owns 25,702 shares of the medical instruments supplier's stock valued at $488,000 after purchasing an additional 3,449 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in DENTSPLY SIRONA by 13.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 551,442 shares of the medical instruments supplier's stock valued at $10,466,000 after purchasing an additional 65,308 shares in the last quarter. Vise Technologies Inc. bought a new stake in DENTSPLY SIRONA during the fourth quarter valued at about $195,000. Finally, Wealth Enhancement Advisory Services LLC boosted its position in DENTSPLY SIRONA by 222.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 38,786 shares of the medical instruments supplier's stock valued at $736,000 after purchasing an additional 26,748 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.